U.S. CDC, Pfizer Vaccine Booster Shot 6→5 Months FDA Shortcut Plan Final Approval

The U.S. Centers for Disease Control and Prevention (CDC) has approved a proposal to shorten the interval between booster shots (boost doses) of the Pfizer vaccine once morest COVID-19 from six months to five months.

The CDC recommended booster shots 5 months following the second dose of Pfizer vaccine, Archyde.com reported.

The CDC approved the recommendations made by the US Food and Drug Administration (FDA) the day before.

However, the CDC has maintained the existing policy of receiving booster shots 2 months and 6 months following complete inoculation for Johnson & Johnson (J&J) and Moderna vaccines, respectively.

The CDC also states that children aged 5-11 with moderate to severe immunocompromised immunity may receive a booster shot 28 days (four weeks) following their second Pfizer vaccine.

Earlier, the FDA also announced that booster shots can be given to some children aged 5 to 11 with weakened immune systems.

The CDC will hold an advisory committee on the 5th to discuss whether to allow booster shots for children aged 12 to 15 years of Pfizer vaccine.

The FDA recommended shortening the duration of Pfizer vaccine booster shots the day before, and announced that it would allow booster shots for 12-15 year olds.

.

Leave a Replay